skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi,
is the current debt level for ABBV to risky in the current economic environment or is the projected cash flow enough to reduce this risk? Might this cause dividend increases in the future not to happen?
In some of your answers to questions from members regarding health care stocks in the US, you often mention the election as a possible concern. Could you expand on this please? I assume you mean that one party is better than the other for this sector.
Thanks,
Dan
Read Answer Asked by Daniel on November 02, 2020
Q: RE; Healthcare,
I currently have a limited amount of healthcare exposure in my portfolio and looking to build the allocation. I hold some MDT in my US account, I have been adding to that holding on dips. I would appreciate hearing your favourite US and Canadian healthcare stocks.. Please provide your top choices for US and Canada plus any particular ETF's you like in the healthcare sector. Thank you, Patrick
Read Answer Asked by Patrick on November 02, 2020
Q: Hello Peter,
I would like your assessment of DXCM after the earnings call. The growth rate has not tapered, the valuation on P/E and P/B looks to be in line with growth companies such as CRWD, VEEV etc. The product has now access to the european market, which probably was not part of the equation earlier quarter. Apart from the impending retirement of a senior executive, what would cause the sharp drop relative to the market?
Would this be a candidate for capital loss sale and buy in Dec or Jan?
Look forward to your thoughts.
Regards
Rajiv
Read Answer Asked by Rajiv on October 29, 2020
Q: Sorry. In my question yesterday I forgot to specify that I am most interested in US listed companies. I have done really well with WELL. Thanks
Read Answer Asked by gary on October 28, 2020
Q: Your answer to Jo-Anne's question this morning about Reliq's contract announcement seems fair (another 'good' contract but previous one's haven't translated into much revenue).

However, there was a 2nd simultaneous press release regarding a 'Non-Brokered Private Placement' in which they announce their on-boarding partners (one of them being the new contract announcement this morning) have invested in the company. At first a raise at the low share price seems negative but when your clients invest in your company, you would think they'd be motivated to onboard patients to increase revenue. Does this drastically change the risk/reward for an investor in RHT?
Read Answer Asked by Brent on October 28, 2020
Q: good morning, I would like to know if there are a couple of heath care ETFs that pay a dividend as well, that you think will be good buys. thank you.
Read Answer Asked by jim on October 27, 2020
Q: Do you have a favorite - or2 - in this space? I can tolerant medium risk and would be looking for growth more than income. Thanks
I find the new charts very useful,
Read Answer Asked by gary on October 27, 2020
Q: In order to increase my holdings in Healthcare, I bought Theratechnologies 2 years ago at $7.21 when 5i was bullish on the stock. The stock did quite well for awhile and I was very happy. It closed on Friday at $2.68 (not so happy anymore). Is this company expected to recover or should I accept my losses and sell?
Read Answer Asked by Ray on October 26, 2020
Q: Hi Group I have held GILD for 2 yrs and its just keeps going down is it time to take the loss ? (down 25%) also owned ABBV for 2 yrs also it to is a loser I know you like it please explain why I should continue to hold or? lastly GUD is a dog that I have been holding since the $10 plus days (they clearly are long gone is this a candidate for tax loss selling? appreciate your help on the above 3 questions
Read Answer Asked by Terence on October 22, 2020
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!